Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Shandong Weigao Group Medical Polymer Co ( (HK:1066) ).
Shandong Weigao Group Medical Polymer Company Limited has outlined the terms of reference for its Nomination Committee, which is responsible for reviewing the board’s structure and composition, identifying suitable director candidates, and making recommendations for board appointments and succession planning. This move is aimed at enhancing the company’s governance and aligning its board composition with its corporate strategy to promote shareholder value.
The most recent analyst rating on (HK:1066) stock is a Buy with a HK$6.40 price target. To see the full list of analyst forecasts on Shandong Weigao Group Medical Polymer Co stock, see the HK:1066 Stock Forecast page.
More about Shandong Weigao Group Medical Polymer Co
Shandong Weigao Group Medical Polymer Company Limited is a joint stock limited company incorporated in China, operating primarily in the medical polymer industry. The company focuses on manufacturing and providing medical devices and related products.
Average Trading Volume: 11,858,205
Technical Sentiment Signal: Buy
Current Market Cap: HK$27.86B
See more insights into 1066 stock on TipRanks’ Stock Analysis page.